Abridge
NativeAI NativePrivateUpdated November 15, 2026The clinical AI company that did what most healthcare AI companies skip — published their evidence.
- Website
- abridge.com
- Founded
- 2018
- CEO
- Shiv Rao
- HQ
- Pittsburgh, PA, United States
- Stage
- Private
- Revenue
- Not disclosed
- Total Funding
- $1.1B
- Employees
- 501-1000
Executive Summary
Updated Nov 8, 2026
What they do
- Ambient AI that turns patient-clinician conversations into structured, EHR-ready clinical notes
- Expanding into prior authorization, coding, nursing documentation and point-of-care decision support
- Clinician intelligence platform built with Nvidia, including a foundation model for clinical conversations
Why it matters
- Used by 300+ health systems serving about 250M patients, including Mayo, Duke and Kaiser
- Won Best in KLAS for ambient AI two years running, ahead of Microsoft's Nuance
- Very well funded, raising roughly $800M at a $5.3B valuation with a16z and Khosla
Best fit
- Large Epic-based health systems rolling out ambient documentation to all clinicians
- Physician-heavy organizations focused on reducing burnout and documentation time
- Provider groups wanting real-time prior authorization and billable notes from visit conversations
Watch-outs
- Epic's built-in AI charting and Microsoft Dragon Copilot threaten its standalone value
- Class actions over patient consent name Abridge customers such as Sutter and Sharp
- Enterprise-only contracts with custom pricing and no self-serve option for small practices
Products & Offerings
Abridge Ambient Clinical Documentation
Ambient AI that records patient visits and produces structured, specialty-aware notes inside Epic and other EHRs.
Clinician Intelligence Platform
Platform announced in June 2026 that coordinates clinical, financial and evidence-based decisions from the clinical conversation, including nursing workflows and real-time claims.
Contextual Reasoning Engine
Reasoning layer that reads conversations and chart data to support coding, billable notes and payer requirements.
Real-Time Prior Authorization (with Availity)
Combines Abridge's reasoning engine with Availity's FHIR-based utilization management APIs to aim for payer decisions during the visit.
Abridge Assistant
AI assistant for clinicians that answers queries with evidence drawn from partnered medical journals and patient context.
Latest News
01net · 3 days ago
PositiveBusiness Wire · 4 days ago
PositiveCASRAI · 6 days ago
NeutralThe Business Journals · 6 days ago
NegativeModern Healthcare · 9 days ago
NegativeUpdated Nov 8, 2026
Abridge is the leading independent ambient documentation vendor, with top KLAS ratings, more than 300 health system deployments and strong funding, so most large health systems should include it in any ambient AI selection. Run it head-to-head against Epic's native AI charting and Microsoft Dragon Copilot, since Mount Sinai chose Microsoft after a bake-off. Before go-live, set clear patient consent workflows and contract terms on data use.
Signal Provenance
Latest observation date and source for each signal category
| Signal Category | Last Updated | Source |
|---|---|---|
Funding Signals Last funding round, Funding stage | Nov 15, 2026 | Cited web research |
Hiring Velocity Headcount, Headcount growth | Nov 15, 2026 | Research agents (estimate) |
Technical Output Research papers, GitHub activity | Nov 15, 2026 | Hugging Face Hub + news feed + research agents |
News Sentiment News mentions, News sentiment | Nov 15, 2026 | Verified news feed |
Partnership Signals Enterprise partnerships, Distribution partners | Nov 15, 2026 | Research agents (estimate) |
Revenue Indicators ARR estimate, Revenue growth | Nov 15, 2026 | Research agents (estimate) |
Leadership Signals CEO tenure, Founder-led | Nov 15, 2026 | Research agents (estimate) |
Competitive Position Category rank, Market share | Nov 15, 2026 | Research agents (estimate) |
Why this Bluescore?
6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology
Abridge's Bluescore of 41.4 rests most on Customer Adoption (6.3, top 15%) and Investment Momentum (6.7, top 21%). Its weakest area is Business Model & Revenue (3.3, 15th percentile).
In plain English
Abridge's Bluescore of 41.4 out of 100 is held back mainly by Business Model & Revenue, at 3.3 of 10 and the 15th percentile among the AI250, and Talent & Research, at 2.5 of 10 and the 18th percentile. Its strongest areas are Customer Adoption, at 6.3 of 10 and the 85th percentile, and Investment Momentum, at 6.7 of 10 and the 79th percentile, which add 8.2 of 13 and 6.7 of 10 points. The biggest lever is Business Model & Revenue, which carries a 21% weight and still has 14.0 points left, so a stronger score there would move the Bluescore more than any other dimension.
Written by AI from the scores below and checked against them; updated nightly.
Risks
Updated Nov 8, 2026